Formulary policy for cholesterol reduction.
D003362:Cost-Benefit Analysis; D004358:Drug Therapy / Q000191:economics; D005569:Formularies as Topic / Q000592:standards*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008148:Lovastatin / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use
D009525:Niacin; D008148:Lovastatin